Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review. - Wikidata - wikimedia - TriplyDB

Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review.

Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review.

http://www.wikidata.org/entity/Q37960507

about

Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line.Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice.Decrease of let-7f in low-dose metronomic Paclitaxel chemotherapy contributed to upregulation of thrombospondin-1 in breast cancer.Nanolipolee-007, a novel nanoparticle-based drug containing leelamine for the treatment of melanoma.Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model Targeted Mesoporous Iron Oxide Nanoparticles-Encapsulated Perfluorohexane and a Hydrophobic Drug for Deep Tumor Penetration and Therapy The mesenchymal tumor microenvironment: a drug-resistant niche.The treatment patterns, efficacy, and safety of nab (®)-paclitaxel for the treatment of metastatic breast cancer in the United States: results from health insurance claims analysis.Nanocrystals for the parenteral delivery of poorly water-soluble drugs Nanooncology: the future of cancer diagnosis and therapy.Recent advances in multifunctional silica-based hybrid nanocarriers for bioimaging and cancer therapy.Protein-polymer hybrid nanoparticles for drug delivery.Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents SEOM clinical guidelines for the management of metastatic breast cancer 2013.Analysis of biotinylated generation 4 poly(amidoamine) (PAMAM) dendrimer distribution in the rat brain and toxicity in a cellular model of the blood-brain barrier.Enhanced Targeted Delivery of Cyclodextrin-Based Supermolecules by Core-Shell Nanocapsules for Magnetothermal Chemotherapy.In vitro and in vivo evaluation of effect of excipients in local delivery of paclitaxel using microporous infusion balloon catheters.

P2860

Q26745710-977A37E8-01E7-4476-81E3-FC81051B82C3 Q27336445-7EB6C1F9-D74D-4D20-927B-8F13C66DF048 Q30436623-76FE5C05-F0BD-45A0-9216-2A4452B3B691 Q34780933-50EB6F8A-579A-4731-8C79-892F19AA85A5 Q35225907-0BF7FFD6-C811-47DF-9747-189C8D1240C8 Q35538164-18430CBA-1300-4DE3-8802-EA8B684A813E Q36056206-92E0EB80-6632-447E-A122-865ECF85D6EC Q36187755-30F2B3EE-DFF8-4F73-B674-CA96BE314BD9 Q36416904-B91D0287-B17B-4C59-9C57-106B3A48A7AB Q38104343-D3297236-F5CC-4D3A-8ABB-2929B1974DBD Q38151549-9C4BDDE6-12FB-43B9-BA17-62252451E67C Q38691862-E95F821C-388F-46E7-A41D-30D1C0D9CD7E Q39298620-EAF5E927-C066-442C-BE34-F65E65B5A12A Q42755952-90D5EAFD-B9BE-41C1-A02F-CC04B6523F80 Q46011982-A5C6C6AA-6708-4800-A305-534479BBDFB5 Q49017113-C20282EC-6B69-45CB-9F84-6B1132FB685C Q51283767-9C00836F-0AF1-402B-A8A7-B8276E964DD0 Q51667021-A7CC728A-DA60-463B-B60E-16B1086DDCA2

P2860

Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review.

http://www.wikidata.org/entity/Q37960507

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review.

@en

Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review.

@nl

type

label

Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review.

@en

Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review.

@nl

prefLabel

Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review.

@en

Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review.

@nl

P1433

Q37960507-876F3604-D240-4008-B67A-52E45F2E7A87

P1476

Q37960507-80606220-71AE-41FD-946E-9E46E3921ACB

P2093

Q37960507-5AF6711E-E5C1-4BFC-96EB-FD5E59DB986A

Q37960507-819BDA75-26BC-4912-B77A-1576FCFC6EE9

Q37960507-D381ECF4-0FFF-425D-A9E8-032200B9A21B

Q37960507-F2798E8B-A960-436C-821E-2C7837C8EE86

P2860

Q37960507-15D094EB-08F2-47B9-8331-B5DD6E08B0AA

Q37960507-18F10299-DE69-4FE1-8099-304F5400BCFE

Q37960507-1C516EB7-EF82-409E-9F43-794BD7D7506D

Q37960507-408DED6C-609B-4B7B-8E02-9786E8111458

Q37960507-624BA5CD-AA63-4303-A2CB-1600F109562E

Q37960507-6B559E85-A0EB-4D6B-8A5D-1AC0B3D953C9

Q37960507-6EA5D3A8-D423-43BC-8C67-6647E6506AF7

Q37960507-71F3A280-3E10-46CA-A5D3-83F6425C4465

Q37960507-726F32E0-35FF-426D-816B-AC5153A67159

Q37960507-84D0CDAF-536D-4B37-9FE6-9B7D2C42165E

P304

Q37960507-DC713BCF-2AFD-4334-B327-317B5B7C0435

P31

Q37960507-E02501FB-F7D7-4138-B6BE-5CE6AA5BE73E

P356

Q37960507-A42FACE5-B57D-402D-9132-34E12CF44386

P407

Q37960507-0EBF140C-F380-4B24-B9E0-6A20490A7203

P433

Q37960507-4A97FD2F-8DDB-42F2-A203-A88058031406

P478

Q37960507-98AFBCB5-E493-4D60-AE30-CEF067A70433

P577

Q37960507-C6E8F27B-7BB9-45B6-B9B9-4E3BB7C7A7DA

P698

Q37960507-C490ABB6-4D7D-4702-AF26-FDF13FD0320E

P356

P1433

Expert Review of Clinical Pharmacology

P1476

Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review.

@en

P2093

Alberto J Montero

http://www.w3.org/2001/XMLSchema#string

Betsy Adams

http://www.w3.org/2001/XMLSchema#string

C Marcela Diaz-Montero

http://www.w3.org/2001/XMLSchema#string

Stefan Glück

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2009

Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation.

Paclitaxel albumin-bound particles (abraxane) in combination with bevacizumab with or without gemcitabine: early experience at the University of Miami/Braman Family Breast Cancer Institute.

Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.

Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies.

A systematic review of taxane-containing regimens for metastatic breast cancer.

Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane) in combination with gemcitabine in patients with metastatic breast cancer (N0531).

International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.

Weekly paclitaxel in the adjuvant treatment of breast cancer.

Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer.

P304

329-334

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ECP.11.7

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22114779

http://www.w3.org/2001/XMLSchema#string